Severe forms of COVID-19 or influenza can trigger the development of lung cancer years after recovery. This was reported on ...
Racura Oncology’s lead drug candidate RC220 has cleared an important regulatory hurdle after receiving governance approval from Monash Health to start a phase I clinical trial in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results